Protein malnutrition is common in chronic kidney disease. This study will evaluate supplements currently available on the market in people with chronic kidney disease with end-stage kidney failure under hemodialysis.

We are seeking those with lived experience in nephrology care of all ages from all corners of the country to join the Capacity Building and Communications and Engagement Committees of the Canadian Nephrology Trials Network.

Seeking patient partners to identify mental health concerns, including those among Indigenous individuals receiving hemodialysis.

We are looking for people like you or “patient partners” to co-create an app to help those receiving in-center hemodialysis live, feel, and be well.

Looking for patient partners to help us develop a video to highlight the patient experience on topics related to deprescribing and participation in kidney research.

Join other people living with chronic kidney disease and learn from a team of wellness and kidney experts.

The purpose of this study is to determine if spironolactone reduces death or hospitalization for heart failure and is well tolerated in patients that require dialysis.

A study examining the impact of sodium deposition on common symptoms experienced by people with impaired kidney function.

This study will test whether nabilone, a synthetic (non-natural) medication derived from cannabis, improves symptoms of itch in hemodialysis compared to placebo.

A new patient/public advisory team will help make organ and tissue donation and transplantation more equitable for 2SLGBTQIA+ people.